School of Cardiovascular and Metabolic Health, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Department of Women and Children's Health, King's College London, London, UK.
J Nephrol. 2024 Apr;37(3):597-610. doi: 10.1007/s40620-023-01830-6. Epub 2024 Jan 18.
Pregnancy involves major adaptations in renal haemodynamics, tubular, and endocrine functions. Hypertensive disorders of pregnancy are a leading cause of maternal mortality and morbidity. Uromodulin is a nephron-derived protein that is associated with hypertension and kidney diseases. Here we study the role of urinary uromodulin excretion in hypertensive pregnancy.
Urinary uromodulin was measured by ELISA in 146 pregnant women with treated chronic hypertension (n = 118) and controls (n = 28). We studied non-pregnant and pregnant Wistar Kyoto and Stroke Prone Spontaneously Hypertensive rats (n = 8/strain), among which a group of pregnant Stroke-Prone Spontaneously Hypertensive rats was treated with either nifedipine (n = 7) or propranolol (n = 8).
In pregnant women, diagnosis of chronic hypertension, increased maternal body mass index, Black maternal ethnicity and elevated systolic blood pressure at the first antenatal visit were significantly associated with a lower urinary uromodulin-to-creatinine ratio. In rodents, pre-pregnancy urinary uromodulin excretion was twofold lower in Stroke-Prone Spontaneously Hypertensive rats than in Wistar Kyoto rats. During pregnancy, the urinary uromodulin excretion rate gradually decreased in Wistar Kyoto rats (a twofold decrease), whereas a 1.5-fold increase was observed in Stroke-Prone Spontaneously Hypertensive rats compared to pre-pregnancy levels. Changes in uromodulin were attributed by kidney injury in pregnant rats. Neither antihypertensive changed urinary uromodulin excretion rate in pregnant Stroke-Prone Spontaneously Hypertensive rats.
In summary, we demonstrate pregnancy-associated differences in urinary uromodulin: creatinine ratio and uromodulin excretion rate between chronic hypertensive and normotensive pregnancies. Further research is needed to fully understand uromodulin physiology in human pregnancy and establish uromodulin's potential as a biomarker for renal adaptation and renal function in pregnancy.
妊娠涉及肾脏血液动力学、肾小管和内分泌功能的重大适应性改变。妊娠高血压疾病是孕产妇死亡和发病的主要原因。尿调蛋白是一种与高血压和肾脏疾病相关的肾源性蛋白。本研究旨在探讨尿调蛋白排泄在妊娠高血压中的作用。
采用 ELISA 法检测 146 例慢性高血压孕妇(n=118)和对照组孕妇(n=28)的尿调蛋白。我们研究了非妊娠和妊娠 Wistar Kyoto 及卒中易发性自发性高血压大鼠(n=8/品系),其中一组妊娠卒中易发性自发性高血压大鼠分别用硝苯地平(n=7)或普萘洛尔(n=8)治疗。
在孕妇中,慢性高血压的诊断、产妇体重指数增加、黑人产妇种族和首次产前检查时的收缩压升高,与尿调蛋白与肌酐比值降低显著相关。在啮齿动物中,妊娠前尿调蛋白排泄量在卒中易发性自发性高血压大鼠中较 Wistar Kyoto 大鼠低两倍。在妊娠期间,Wistar Kyoto 大鼠的尿调蛋白排泄率逐渐降低(降低两倍),而卒中易发性自发性高血压大鼠则较妊娠前增加了 1.5 倍。怀孕大鼠的肾脏损伤导致尿调蛋白的变化。两种降压药均未改变妊娠卒中易发性自发性高血压大鼠的尿调蛋白排泄率。
总之,我们证明了尿调蛋白/肌酐比值和尿调蛋白排泄率在慢性高血压和正常妊娠期间存在妊娠相关的差异。需要进一步研究以充分了解人类妊娠中尿调蛋白的生理学,并确定尿调蛋白作为妊娠期间肾脏适应和肾功能的潜在生物标志物的作用。